Real-time enrollment status for this small cell lung cancer extensive stage clinical trial
Current Status
Recruiting
Checked: September 16, 2026 at 1:31 AM UTC
| NCT Number | NCT07625644 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer Extensive Stage |
| Phase | PHASE3 |
| Target Enrollment | 550 participants |
| Active Locations | 7 sites in the US |
| Sponsor | SystImmune Inc. |
| Last Updated on CT.gov | September 15, 2026 (Yesterday) |
As of September 16, 2026: Clinical trial NCT07625644 is currently recruiting participants. This phase3 study for small cell lung cancer extensive stage is actively seeking new participants at 7 locations across the United States. The study is sponsored by SystImmune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07625644 is actively recruiting participants as of September 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07625644 was last updated Yesterday (September 15, 2026). HelloStudys verifies this status automatically.